Your browser doesn't support javascript.
loading
Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial.
Guadagnolo, B Ashleigh; Bassett, Roland L; Mitra, Devarati; Farooqi, Ahsan; Hempel, Caroline; Dorber, Courtney; Willis, Tiara; Wang, Wei-Lien; Ratan, Ravin; Somaiah, Neeta; Benjamin, Robert S; Torres, Keila E; Hunt, Kelly K; Scally, Christopher P; Keung, Emily Z; Satcher, Robert L; Bird, Justin E; Lin, Patrick P; Moon, Bryan S; Lewis, Valerae O; Roland, Christina L; Bishop, Andrew J.
Affiliation
  • Guadagnolo BA; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA. Electronic address: aguadagn@mdanderson.org.
  • Bassett RL; Department of Biostatistics, MD Anderson Cancer Center, Houston, TX, USA.
  • Mitra D; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Farooqi A; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Hempel C; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Dorber C; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Willis T; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Wang WL; Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA.
  • Ratan R; Department of Sarcoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Somaiah N; Department of Sarcoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Benjamin RS; Department of Sarcoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Torres KE; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Hunt KK; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Scally CP; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Keung EZ; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Satcher RL; Department of Orthopaedic Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Bird JE; Department of Orthopaedic Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Lin PP; Department of Orthopaedic Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Moon BS; Department of Orthopaedic Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Lewis VO; Department of Orthopaedic Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Roland CL; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
  • Bishop AJ; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Lancet Oncol ; 23(12): 1547-1557, 2022 12.
Article in En | MEDLINE | ID: mdl-36343656

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Radiation Injuries / Sarcoma / Soft Tissue Neoplasms Type of study: Prognostic_studies Limits: Adolescent / Adult / Humans Language: En Journal: Lancet Oncol Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Radiation Injuries / Sarcoma / Soft Tissue Neoplasms Type of study: Prognostic_studies Limits: Adolescent / Adult / Humans Language: En Journal: Lancet Oncol Year: 2022 Document type: Article